Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment
- PMID: 23317802
- DOI: 10.1179/1743132812Y.0000000117
Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment
Abstract
Objectives: Recent evidence supports the involvement of RCAN1 in Down syndrome and Alzheimer's disease. To better assess this, we generated and analyzed transgenic mice overexpressing human RCAN1 isoform 4 in neurons.
Methods: Cognitive behavioral (Morris water maze, open field, zero maze, elevated plus maze assays); cognitive-associated proteins (CREB, ERK and Tau Western immunoblotting); motor coordination (Rotarod assay); structural abnormalities (immunohistological analyses), and proinflammatory cytokines (cytometric bead assay) were measured in young (2 month) and old (18 month) transgenics and compared with wild type controls.
Results: In old mice, male but not female transgenics exhibited a significant decrease in anxiety as compared with wild type controls, whereas female but not male transgenic mice exhibited significantly less motor coordination. No differences were observed in the Morris water maze (spatial learning). pERK levels were reduced in transgenic males but not females, while no differences were observed between genotypes for pCREB and pTau. In young mice, a modest learning and exploratory behavior was observed in transgenic mice using a limited number of mice, and at higher N values, pCREB and pERK (but not pTau) levels were reduced in transgenics. No macro- and micro-scopic structural abnormalities or proinflammatory cytokine level differences were observed.
Discussion: These results indicate that elevated RCAN1 isoform 4 in neurons leads to a modest cognition-related impairment that is overall stronger at 2 months, suggesting a compensatory adaptation over time. These RCAN1 isoform 4 effects may contribute to at least some of the observed phenotypes in individuals with Down syndrome and Alzheimer's.
Similar articles
-
Mice transgenic for reduced folate carrier: an animal model of Down syndrome?Amino Acids. 2009 Feb;36(2):349-57. doi: 10.1007/s00726-008-0091-0. Epub 2008 Apr 15. Amino Acids. 2009. PMID: 18414976
-
Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes.Brain Res. 2010 Aug 12;1348:149-55. doi: 10.1016/j.brainres.2010.06.011. Epub 2010 Jun 15. Brain Res. 2010. PMID: 20558146
-
RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.FEBS J. 2007 Apr;274(7):1715-24. doi: 10.1111/j.1742-4658.2007.05717.x. Epub 2007 Feb 28. FEBS J. 2007. PMID: 17331188
-
Fish oil improves gene targets of Down syndrome in C57BL and BALB/c mice.Nutr Res. 2015 May;35(5):440-8. doi: 10.1016/j.nutres.2015.02.007. Epub 2015 Mar 1. Nutr Res. 2015. PMID: 25799055
-
The neuronal and endocrine roles of RCAN1 in health and disease.Clin Exp Pharmacol Physiol. 2018 Apr;45(4):377-383. doi: 10.1111/1440-1681.12884. Epub 2017 Nov 29. Clin Exp Pharmacol Physiol. 2018. PMID: 29094385 Review.
Cited by
-
NF-κB signaling pathway inhibition suppresses hippocampal neuronal apoptosis and cognitive impairment via RCAN1 in neonatal rats with hypoxic-ischemic brain damage.Cell Cycle. 2019 May;18(9):1001-1018. doi: 10.1080/15384101.2019.1608128. Epub 2019 May 3. Cell Cycle. 2019. Retraction in: Cell Cycle. 2022 Apr;21(7):764. doi: 10.1080/15384101.2022.2046806. PMID: 30990350 Free PMC article. Retracted.
-
RCAN1 overexpression exacerbates calcium overloading-induced neuronal apoptosis.PLoS One. 2014 Apr 21;9(4):e95471. doi: 10.1371/journal.pone.0095471. eCollection 2014. PLoS One. 2014. PMID: 24751678 Free PMC article.
-
The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease.Dis Model Mech. 2016 Mar;9(3):295-306. doi: 10.1242/dmm.018069. Epub 2015 Dec 10. Dis Model Mech. 2016. PMID: 26659252 Free PMC article.
-
RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease.Acta Neuropathol. 2015 Dec;130(6):829-43. doi: 10.1007/s00401-015-1499-8. Epub 2015 Oct 24. Acta Neuropathol. 2015. PMID: 26497675 Free PMC article.
-
Resveratrol Attenuates Microglial Activation via SIRT1-SOCS1 Pathway.Evid Based Complement Alternat Med. 2017;2017:8791832. doi: 10.1155/2017/8791832. Epub 2017 Jul 11. Evid Based Complement Alternat Med. 2017. PMID: 28781601 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous